Myovant Sciences Ltd. (the company became a subdivision of the company Sumitomo Pharma America, Inc. (SMPA)) (MYOV)
ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering
ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering
There are no comments here yet...